Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

doctor looking at CLTI patient's leg

FDA grants bioresorbable scaffold system its breakthrough device designation to treat infrapopliteal lesions

The new drug-eluting device was designed to provide both stability and flexibility to patients presenting with below-the-knee lesions.  

An FDA panel will discuss its recommendations related to Abbott's TriClip G4 transcatheter edge-to-edge repair (TEER) system for tricuspid regurgitation.

FDA advisory panel votes in favor of Abbott’s TriClip device for tricuspid regurgitation

After hours of discussion, the panel determined that the benefits of using the TriClip G4 TEER system to treat TR outweigh any potential risks. 

doctor examines patient data on their tablet

New American College of Cardiology registry focuses on data from outpatient ambulatory surgical centers

The ACC launched its latest registry knowing that volumes at these outpatient facilities are expected to rise in the years ahead. 

what is a flexitarian diet? plant-based but limited meats

Flexitarian diet, a plant-based option that includes small amounts of meat, linked to key cardiovascular benefits

The study, designed to compare flexitarians with vegans and omnivores, focused on young and middle-aged adults in good health who had been following the same diet for at least one full year.

An FDA panel will discuss its recommendations related to Abbott's TriClip G4 transcatheter edge-to-edge repair (TEER) system for tricuspid regurgitation.

FDA panel to consider Abbott’s TriClip device for tricuspid regurgitation

The panel's decision will be based on data from the TRILUMINATE study, which was ultimately positive for Abbott, but did lead to certain questions about patient outcomes.

Thumbnail

Salt substitutes reduce hypertension risk by up to 40%

Many patients do not want to limit their salt intake, even when a doctor tells them the numerous health benefits. Salt substitutes may represent another way forward. 

AI cardiology heart artificial intelligence deep learning

AI could be a game-changer for TAVR, but cardiologists remain ‘irreplaceable’

The rise of TAVR as a go-to treatment option for many AS patients has been one of the biggest stories in cardiology for several years now. How will advanced AI models impact this trend going forward? 

New lawsuit alleges a woman’s brain bleed was mistaken for drunken driving, causing significant harm

A Washington woman was pulled over and arrested because a state trooper thought she was driving under the influence. It turned out that she was not drunk, but suffering from a frontal-lobe subdural hematoma. She has now filed a lawsuit against the county. 

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.